GSK plc (GSKl)

BATS Europe
Currency in GBP
1,421.50
-11.25(-0.79%)
Closed

GSKl Income Statement

Advanced Income Statement
Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa24,35424,69629,32430,32831,376
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-27.85%+1.4%+18.74%+3.42%+3.46%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa7,3218,0339,4078,3888,845
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa17,03316,66319,91721,94022,531
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-25.82%-2.17%+19.53%+10.16%+2.69%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa69.94%67.47%67.92%72.34%71.81%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa10,98311,02912,59513,53715,962
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-25.59%+0.42%+14.2%+7.48%+17.91%
aa.aaaa.aaaa.aaaa.aaaa.aa4,3974,6275,1535,8236,078
aa.aaaa.aaaa.aaaa.aaaa.aa7,0416,7848,1799,15610,853
aa.aaaa.aaaa.aaaa.aaaa.aa-455-382-737-1,442-969
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa6,0505,6347,3228,4036,569
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-26.23%-6.88%+29.96%+14.76%-21.83%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa24.84%22.81%24.97%27.71%20.94%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-818-749-757-602-547
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-2.51%+8.44%-1.07%+20.48%+9.14%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-844-762-819-710-669
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa261362108122
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa927-48-80-3
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa5,2414,9126,5177,7216,019
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa2,85755221561-
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-1,508-1,442-1,039-1,215-2,195
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa5,1703,5995,6286,0643,477
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-16.89%-30.39%+56.38%+7.75%-42.66%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa21.23%14.57%19.19%19.99%11.08%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa6783707756526
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa5,9794,58515,4165,3082,951
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-230-200-460-380-376
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa5,7494,38514,9564,9282,575
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+23.77%-23.73%+241.07%-67.05%-47.75%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa23.61%17.76%51%16.25%8.21%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa4,8733,3164,4614,9282,575
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.220.831.111.220.63
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+4.29%-32.33%+33.76%+9.76%-48.07%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.210.821.091.20.62
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+4.45%-32.34%+33.5%+9.8%-48.12%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa3,9814,0034,0264,0524,077
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa4,0304,0524,0844,1114,142
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa110.610.580.61
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa0%0%-38.75%-5.31%+5.17%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa8,1007,7569,08910,3049,240
EBITDA Growth
aa.aa